Literature DB >> 21606976

Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis.

Nicole C Suares1, Alexander C Ford.   

Abstract

OBJECTIVES: Chronic idiopathic constipation (CIC) is a common functional gastrointestinal disorder in the community, yet no previous systematic review and meta-analysis has estimated the global prevalence, or potential risk factors for the condition.
METHODS: MEDLINE, EMBASE, and EMBASE Classic were searched (up to December 2010) to identify population-based studies reporting the prevalence of CIC in adults (≥15 years), according to self-report, questionnaire, or specific symptom-based criteria. The prevalence of CIC was extracted for all studies, and according to country, age, gender, socioeconomic status, and presence or absence of irritable bowel syndrome (IBS) where reported. Pooled prevalence overall, and according to study location and certain other characteristics, as well as odds ratios (ORs), with 95% confidence intervals (CIs) were calculated.
RESULTS: Of the 100 papers evaluated, 45 reported the prevalence of CIC in 41 separate study populations, containing 261,040 subjects. Pooled prevalence of CIC in all studies was 14% (95% CI: 12-17%). The prevalence of CIC was lower in South East Asian studies, and in studies using the Rome II or III criteria. The prevalence of CIC was higher in women (OR: 2.22; 95% CI: 1.87-2.62), and increased with age and lower socioeconomic status. The prevalence was markedly higher in subjects who also reported IBS (OR: 7.98; 95% CI: 4.58-13.92), suggesting common pathogenic mechanisms.
CONCLUSIONS: Pooled prevalence of CIC in the community was 14%, and of similar magnitude in most geographical regions. Rates were higher in women, older individuals, and those of lower socioeconomic status. Presence of IBS was strongly associated with CIC.

Entities:  

Mesh:

Year:  2011        PMID: 21606976     DOI: 10.1038/ajg.2011.164

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  193 in total

1.  Clinical features of constipation in general practice in Italy.

Authors:  Carmelo Cottone; Cesare Tosetti; Giuseppe Disclafani; Enzo Ubaldi; Rosanna Cogliandro; Vincenzo Stanghellini
Journal:  United European Gastroenterol J       Date:  2014-06       Impact factor: 4.623

2.  Comparative efficacy and safety of lactulose plus paraffin vs polyethylene glycol in functional constipation: a randomised clinical study.

Authors:  T Piche; M Dapoigny
Journal:  United European Gastroenterol J       Date:  2020-06-28       Impact factor: 4.623

3.  The treatment of functional constipation significantly increased quality of life in children aged 4-17 years.

Authors:  Barış Erdur; Murat Ayar
Journal:  Turk J Gastroenterol       Date:  2020-11       Impact factor: 1.852

4.  Factors associated with persistent and nonpersistent chronic constipation, over 20 years.

Authors:  Rok Seon Choung; G Richard Locke; Enrique Rey; Cathy D Schleck; Charles Baum; Alan R Zinsmeister; Nicholas J Talley
Journal:  Clin Gastroenterol Hepatol       Date:  2012-01-28       Impact factor: 11.382

Review 5.  Functional Disorders: Rectocele.

Authors:  W Conan Mustain
Journal:  Clin Colon Rectal Surg       Date:  2017-02

6.  Plecanatide (Trulance) for Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.

Authors:  Julia A Kamuda; Nissa Mazzola
Journal:  P T       Date:  2018-04

Review 7.  Benefit-Risk Assessment of Plecanatide in the Treatment of Chronic Idiopathic Constipation.

Authors:  Philip B Miner
Journal:  Drug Saf       Date:  2019-05       Impact factor: 5.606

8.  A modified total colonic exclusion for elderly patients with severe slow transit constipation.

Authors:  Q Qian; C Jiang; Y Chen; Z Ding; Y Wu; K Zheng; Q Qin; Z Liu
Journal:  Tech Coloproctol       Date:  2014-01-17       Impact factor: 3.781

Review 9.  Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.

Authors:  Diego Currò; Gianluca Ianiro; Silvia Pecere; Stefano Bibbò; Giovanni Cammarota
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

10.  [Pharmacological treatment of constipation].

Authors:  S Müller-Lissner
Journal:  Internist (Berl)       Date:  2013-04       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.